Teva Stock Is at Its Highest Level in Nearly a Decade. Here's Why It Could Soar Even More.The Motley Fool • 05/15/26
TEVA Q1 Earnings Top Estimates, Branded Drugs Drive Revenues, Stock UpZacks Investment Research • 04/30/26
Teva's 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond TargetsGlobeNewsWire • 04/30/26
Teva Pharmaceutical Industries Limited (TEVA) Q1 2026 Earnings Call TranscriptSeeking Alpha • 04/29/26
Teva Pharmaceutical Industries (TEVA) Reports Q1 Earnings: What Key Metrics Have to SayZacks Investment Research • 04/29/26
Teva Surges As Its New Growth Strategy Hits A Key Inflection PointInvestors Business Daily • 04/29/26
Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined ExecutionGlobeNewsWire • 04/29/26
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva's Pivot to Growth StrategyGlobeNewsWire • 04/29/26
Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care PartnersGlobeNewsWire • 04/15/26
Community Routes: Access to Mental Health Care Provides Continued Funding for Mental Health Services at Free & Charitable ClinicsGlobeNewsWire • 04/14/26
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)GlobeNewsWire • 03/30/26
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026GlobeNewsWire • 03/19/26
Teva Pharmaceutical Industries Limited (TEVA) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptSeeking Alpha • 03/10/26
Teva Pharmaceutical Industries Limited (TEVA) Presents at Leerink Global Healthcare Conference 2026 TranscriptSeeking Alpha • 03/09/26
Billionaire Stanley Druckenmiller Dumped 2 of His Top Performers -- Teva and Taiwan Semiconductor -- and Made This Sector-Based ETF His Fund's New No. 2 HoldingThe Motley Fool • 03/04/26